2004/571/EC: Commission Decision of 23 July 2004 on the purchase by the Community of classical swine fever vaccines and the establishment of Community stocks of those vaccines (notified under document number C(2004) 2056)(Text with EEA relevance)
Date: 2004-07-23
Institutions: European Commission
Subjects: animal plague, disease prevention, minimum stock, vaccine

L 253/20

EN

Official Journal of the European Union

29.7.2004

II

(Acts whose publication is not obligatory)

COMMISSION

COMMISSION DECISION

of 23 July 2004

on the purchase by the Community of classical swine fever vaccines and the establishment of
Community stocks of those vaccines

(notified under document number C(2004) 2056)

(Text with EEA relevance)

(2004/571/EC)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

(5)

Having regard to the Treaty
Community,

establishing the European

Having regard to Council Decision 90/424/EEC of 26 June
1990 on expenditure in the veterinary field (1), and in particular
Article 6(2) and Article 8(2) thereof,

Having regard to Council Directive 2001/89/EC of 23 October
2001 on Community measures for the control of classical swine
fever (2), and in particular Article 18(2) thereof,

Whereas:

Classical swine fever is a threat for domestic and feral
pigs (wild boar) in the Community.

Outbreaks of classical
in domestic pig
holdings can lead to very serious consequences and
economic losses in the Community,
if
they occur in areas with a high density of pigs.

in particular

swine fever

for

rules

The
vaccination of
domestic and feral pigs and the definition of marker
vaccine are laid down in Directive 2001/89/EC.

emergency

applying

(1)

(2)

(3)

(4)

Pursuant
to Commission Decision 2002/106/EC of 1
February 2002 approving a Diagnostic Manual estab-
lishing diagnostic procedures, sampling methods and
criteria for evaluation of
the laboratory tests for the
confirmation of classical swine fever (3), a suitable discri-
minatory test has recently been established to distinguish
vaccinated pigs from pigs naturally infected with classical
swine fever virus. Use of the marker vaccines already
authorised for marketing in the Community
can,
therefore, be envisaged in the event of emergency vacci-
nation of domestic pigs.

Recent experience regarding the control of classical swine
fever in feral pigs in the Community suggests that vacci-
nation of such pigs by means of a vaccine administered
via oral baits can be effective.

For the purpose of reinforcing the Community capability
to respond to classical swine fever,
it is necessary to
purchase an adequate number of doses of marker
vaccine and of vaccine to be administered via oral baits
and to make arrangements for keeping them in stock and
having them rapidly available in case of an emergency.

The measures provided for
accordance with
Committee on the Food Chain and Animal Health,

in this Decision are in
Standing
the

opinion

the

of

(6)

(7)

(8)

HAS ADOPTED THIS DECISION:

The Community already has in stock 1 000 000 doses of
live attenuated vaccine against classical swine fever.

Article 1

(1) OJ L 224, 18.8.1990, p. 19. Decision as last amended by Directive
2003/99/EC of the European Parliament and of the Council
(OJ
L 325, 12.12.2003, p. 31).

(2) OJ L 316, 1.12.2001, p. 5. Directive as amended by the 2003 Act of

Accession.

The Community shall purchase as

1.
soon as possible
1 800 000 doses of marker vaccine against classical swine fever.

(3) OJ L 39, 9.2.2002, p. 71. Decision as amended by Decision

2003/859/EC (OJ L 324, 11.12.2003, p. 55).

29.7.2004

EN

Official Journal of the European Union

L 253/21

The Community shall make arrangements for the storage

2.
and distribution of the vaccine referred to in paragraph 1.

Article 2

The maximum cost of the measures referred to in Article 1 shall
not exceed 1 500 000 EUR.

Article 5

The measures provided for in Article 1(2) and Article 3(2) shall
be carried out by the Commission in cooperation with the
suppliers designated by call for tender.

Article 3

Article 6

The Community shall purchase as

soon as possible
1.
500 000 doses of vaccine against classical swine fever to be
administered orally to feral pigs.

The Community shall make arrangements for the storage

2.
and distribution of the vaccine referred to in paragraph 1.

Article 4

The maximum cost of the measures referred to in Article 3 shall
not exceed 500 000 EUR.

This Decision is addressed to the Member States.

Done at Brussels, 23 July 2004.

For the Commission

David BYRNE
Member of the Commission